Skinvisible
This article was originally published in The Rose Sheet
Executive Summary
Skin care R&D company has entered into a definitive agreement to sell the exclusive North American marketing and distribution rights for its patented Antimicrobial Hand Sanitizer to Dermal Defense, firm reports Feb. 23. Additionally, Skinvisible has extended the deadline of a previous offer to Dermal Defense for rights to the hand sanitizer in territories outside the U.S., Canada and Mexico to March 30, company says. If Dermal Defense accepts the offer, the firm will be required to pay $1 mil. and 5% royalty on all product sales globally, Skinvisible notes...